Costly GLP-1 drugs such as Ozempic, Wegovy, Mounjaro and Zepbound could be covered under the new plan.
www.marketwatch.com
#Weightloss #drugs #covered #Medicare #Medicaid #experimental #program
Related Posts

Here’s Why Dividend Investors Should Take a Second Look
Comcast Corporation (NASDAQ:CMCSA) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. Comcast (CMCSA) Looks…

China Just Blocked Meta’s $2 Billion Acquisition of Manus. Why Does It Seem Like Investors Don’t Care?
ContentsMore News from BarchartAbout Meta Platforms StockMeta Reports Q1 EarningsWhat Do Analysts Think of META Stock? Meta Platforms (META) stock…

Rates move lower, reflecting three Fed rate cuts this year
ContentsMore News from BarchartAbout Meta Platforms StockMeta Reports Q1 EarningsWhat Do Analysts Think of META Stock? The average national rate…

